Christopher A. Kroeger
CIK 1658918 · Chief Executive Officer · last filed 2026-05-18
Christopher A. Kroeger is a Chief Executive Officer who has filed 8 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider sold $3.2M of MPLT on May 18, 2026. Across all open-market trades the lifetime net is −$7.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $41.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$41.49M
2
8
-$7.10M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MPLT | Chief Executive Officer | 1,495,284 | $27.75 | $41.49M | -$7.10M | 7 | 2026-05-18 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Chief Executive Officer | — | $15.90 | — | $0 | 1 | 2018-12-11 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | MPLT | Sell (S) | −118,235 | -$3.21M | EDGAR |
| 2026-05-11 | MPLT | Sell (S) | −68,491 | -$1.95M | EDGAR |
| 2026-05-06 | MPLT | Sell (S) | −49,744 | -$1.41M | EDGAR |
| 2026-04-17 | MPLT | Sell (S) | −19,187 | -$521.1K | EDGAR |
| 2026-02-09 | MPLT | Grant (A) | +23,145 | $0 | EDGAR |
| 2026-01-29 | MPLT | Tax (F) | −204,146 | -$3.67M | EDGAR |
| 2025-10-28 | MPLT | Mixed | +229,588 | $0 | EDGAR |
| 2018-12-11 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | — | $0 | EDGAR |